Intech Investment Management LLC Horizon Therapeutics Public LTD CO Transaction History

Intech Investment Management LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 13, 2023	SELL	$98.98 - $115.74 $168,167 - $196,642	-1,699 Reduced 2.75%	60,182 $6.96 Million
Q2 2023 Aug 09, 2023	BUY	$96.34 - $112.38 $941,530 - $1.1 Million	9,773 Added 18.76%	61,881 $6.36 Million
Q1 2023 May 10, 2023	SELL	$107.32 - $113.5 $85,856 - $90,800	-800 Reduced 1.51%	52,108 $5.69 Million
Q4 2022 Feb 09, 2023	BUY	$62.39 - $113.8 $740,569 - $1.35 Million	11,870 Added 28.92%	52,908 $6.02 Million
Q3 2022 Nov 10, 2022	SELL	$58.92 - $84.67 $984,317 - $1.41 Million	-16,706 Reduced 28.93%	41,038 $2.54 Million

Q2 2022 Aug 10, 2022	BUY	$79.4 - $116.36 $4.58 Million - $6.72 Million	57,744 New	57,744 $4.61 Million

2.07M

20K

Ticker HZNP
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 230,384,000
Description
Horizon Therapeutics Public Limited Company, a biotechnology company, focuses on the discovery, development, and commercialization of medicines that address critical needs for people impacted by rare, autoimmune, and severe inflammatory diseases. The company operates in two segments, Orphan and Inflammation. Its portfolio comprises 12 medicines ...

Get notified when there are updates to the investment portfolio of Intech Investment Management LLC, based on Form 13F filings with the SEC.

Stay updated on Intech Investment Management LLC with notifications on news.